Upregulation correlated with increased proliferation measured by Ki67 protein levels indicating a possible connection between atorvastatin-induced LDLR upregulation and cancer aggressiveness as well as the ability of statins to target breast cancer cells. Here, LDLR is linked to breast carcinoma.